HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,776: | Line 1,776: | ||
| | | | ||
|- | |- | ||
|Primary large B-cell lymphoma of immune-privileged sites||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | |Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center | ||
| Line 1,783: | Line 1,783: | ||
| | | | ||
|- | |- | ||
|Primary cutaneous diffuse large B-cell lymphoma, leg type||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type|Primary cutaneous diffuse large B-cell lymphoma, leg type]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,790: | Line 1,790: | ||
| | | | ||
|- | |- | ||
|Intravascular large B-cell lymphoma||Disease|| || || || || ||GC|| || | |[[HAEM5:Intravascular large B-cell lymphoma|Intravascular large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
|Kate Berry, MBBS, BBus (Hons), Pathology Queensland | |Kate Berry, MBBS, BBus (Hons), Pathology Queensland | ||
| Line 1,797: | Line 1,797: | ||
| | | | ||
|- | |- | ||
|Primary mediastinal large B-cell lymphoma||Disease|| || || || || ||GC|| || | |[[HAEM5:Primary mediastinal large B-cell lymphoma|Primary mediastinal large B-cell lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,804: | Line 1,804: | ||
| | | | ||
|- | |- | ||
|Mediastinal grey zone lymphoma||Disease|| || || || || ||GC|| || | |[[HAEM5:Mediastinal grey zone lymphoma|Mediastinal grey zone lymphoma]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
| | | | ||
| Line 1,811: | Line 1,811: | ||
| | | | ||
|- | |- | ||
|High-grade B-cell lymphoma, NOS||Disease|| || || || || ||GC|| || | |[[HAEM5:High-grade B-cell lymphoma, NOS|High-grade B-cell lymphoma, NOS]]||Disease|| || || || || ||GC|| || | ||
| | | | ||
|Aiko Otsubo, PhD, Indiana University | |Aiko Otsubo, PhD, Indiana University | ||